TELCOR Acquires AI Firm to Overhaul Healthcare's Financial Operations

LINCOLN, NEB. – April 10, 2026 – TELCOR Inc., a major provider of healthcare technology, today announced its acquisition of Sample Healthcare, a Y Combinator-backed artificial intelligence platform. The move signals a seismic shift in the battle against administrative waste and inefficiency in the U.S. healthcare system, aiming to replace manual financial workflows with AI-driven execution.

The acquisition, with financial terms undisclosed, positions Lincoln-based TELCOR to move beyond traditional revenue cycle management (RCM), which has historically focused on organizing and analyzing data. By integrating Sample Healthcare's AI engine, the company plans to automate and execute the complex, labor-intensive tasks that bog down healthcare providers, such as securing prior authorizations, appealing denied claims, and processing vast amounts of unstructured documents.

This strategic pivot comes as the healthcare industry grapples with a perfect storm of financial pressures: soaring administrative costs, chronic staffing shortages, and increasingly aggressive reimbursement denials from payers. This deal is not merely a technology upgrade; it is a direct response to an industry in financial distress.

A Strategic Move in a Pressured Industry

Healthcare providers are navigating an increasingly hostile financial environment. Recent industry data paints a grim picture, with the American Medical Association reporting that claim denial rates climbed to 11% in 2023, costing providers nearly $20 billion annually just to contest them. This administrative friction, combined with labor shortages and wage inflation, has pushed many hospitals and laboratories to the brink.

"The revenue cycle still depends on people moving between documents, payer portals, and phone calls," said Chris Terrano, President of RCM at TELCOR, in a statement announcing the deal. "That model does not scale. TELCOR executes that work with AI, shifting revenue cycle operations from manual processes to automated execution."

This move taps into a rapidly growing market. The U.S. RCM market, valued at over $172 billion in 2024, is projected to expand at over 10% annually through 2030, largely driven by the adoption of technologies that promise to reduce costs and improve collections. TELCOR's acquisition of Sample Healthcare is a clear bet that AI-powered execution, not just analytics, is the future of this market.

Redefining RCM: From Managing Data to Executing Work

The core innovation at the heart of this acquisition is the transition from passive data management to active workflow execution. For decades, RCM software has helped healthcare organizations track claims, identify billing errors, and generate reports. However, the actual work of correcting errors, chasing down payments, and interacting with insurance companies has remained largely in the hands of human staff.

Sample Healthcare's platform is designed to change that. Its AI can interpret unstructured data from sources like clinical notes, faxes, and payer correspondence, and then execute complex, multi-step workflows based on that information. The company claims its technology can be deployed within weeks, allowing clients to target specific high-pain, high-return workflows and expand as the return on investment is proven.

"We founded Sample with a simple belief: administrative headache shouldn't be the bottleneck to accessing care, and AI gives us the tools to make that a reality," said Ankit Ranjan, CEO and co-founder of Sample Healthcare. He noted that partnering with TELCOR provides the scale and reach necessary to bring this technology to the thousands of labs and providers who need it most. The Sample Healthcare team will continue in leadership roles at TELCOR, ensuring continuity for the technology and its existing clients.

The Competitive Landscape Heats Up with AI

TELCOR's acquisition does not occur in a vacuum. It is the latest move in an industry-wide AI arms race. Major players like Waystar, R1 RCM, and Optum have already made significant investments in AI, either through internal development or multi-billion-dollar acquisitions. For instance, R1 RCM's acquisition of Cloudmed was valued at $4.1 billion, highlighting the premium placed on sophisticated AI capabilities that can deliver measurable financial results.

The healthcare IT sector has seen over $150 billion in M&A transactions since 2020, with AI-focused deals representing a rapidly growing share of the activity. By acquiring Sample Healthcare, TELCOR is choosing to buy, rather than build, its way to the forefront of this technological wave. This strategy allows it to rapidly integrate advanced capabilities and compete head-on with larger, publicly-traded rivals.

The company is also taking a unique approach to validating its new technology by deploying the AI capabilities within its own extensive revenue cycle service operations. This “eat your own dog food” strategy is designed to prove the system’s performance in a real-world environment, which could accelerate adoption among a skeptical customer base that has been burned by past technology promises.

Tangible ROI and the Path to Adoption

For healthcare administrators, the allure of AI lies in its potential for concrete, measurable ROI. Industry studies support the claims, with research from Black Book finding that 83% of healthcare organizations saw at least a 10% drop in claim denials within six months of adopting AI-powered RCM tools.

The combined TELCOR and Sample Healthcare platform targets the most costly RCM pain points. By automating prior authorizations, it aims to increase approval rates and prevent denials before they happen. By automating the appeals process, it can accelerate the recovery of revenue that might otherwise be written off. This directly translates into improved cash flow, higher throughput, and the ability to reallocate scarce human resources to more complex, patient-facing tasks.

TELCOR plans a flexible go-to-market strategy, offering Sample Healthcare's platform both as a standalone solution for organizations wanting to augment their existing systems and as a deeply integrated component of the full TELCOR RCM suite. This dual approach broadens the potential market, from small independent labs to large hospital systems.

While the promise is significant, challenges to adoption remain, including data integration complexities and the cultural shift required to trust automated workflows. However, by focusing on executing work rather than simply managing data, TELCOR's acquisition of Sample Healthcare marks a pivotal moment, representing a clear and decisive step toward a future where administrative burdens are systematically dismantled by intelligent automation.